PEN logo

Penumbra (PEN)

Profile

Full Name

Penumbra, Inc.

Ticker Symbol

PEN

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

September 18, 2015

Indexes

Not included

Website

http://www.penumbrainc.com

Employees

4500

Key Details

Price

$298.25(+6.99%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.19B(+12.86% YoY)

Annual EPS

$0.36(-84.48% YoY)

PE ratio

281.37

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$298.25
PEN price is $298.25

30-Day Relative Volume

3.19
PEN 30-day relative volume is 3.19

Price Performance

Price Most recent change

+6.99%
PEN price was up +6.99% on Apr 24, 2025

Price YTD change

+25.59%
PEN price is up +25.59% since January 1st

Price 1-year change

+45.13%
PEN price is up +45.13% year-on-year

Price 3-year change

+59.02%
PEN price is up +59.02% over the past 3 years

Price Range

Price All-time high

$348.67
PEN price is currently -14.46% below its historical high of $348.67

Price 3-year low

$114.86
PEN price is currently +159.65% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.54B
PEN market capitalization is $11.54 billion

Market cap 3-year change

+63.27%
PEN market capitalization is up +63.27% over the past 3 years

Market cap All-time high

$13.21B
PEN market capitalization is currently -12.69% below its historical high of $13.21 billion

Market cap sector rank

93.45%
PEN market capitalization is higher than 93.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.19%
PEN shares outstanding is down -0.19% year-on-year

Shares Outstanding 3-Year Change

+2.67%
PEN shares outstanding is up +2.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.69
PEN beta is 0.69

200-day SMA

$233.13
PEN price is currently +27.93% above its 200-day simple moving average

50-day SMA

$276.38
PEN price is currently +7.91% above its 50-day simple moving average

RSI

64.82
PEN 14-day relative strength index is 64.82

Volume

3.19
PEN 30-day relative volume is 3.19

ATR

$13.01
PEN average true range is $13.01

10-day Historical Volatility

43.47%
PEN 10-day historical volatility is 43.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.19B
PEN annual revenue is $1.19 billion

Revenue Analysts estimate

$1.35B
PEN annual revenue is currently -11.65% lower than the consensus analysts' forecast

Revenue 1-year change

+12.86%
PEN annual revenue is up +12.86% year-on-year

Revenue Sector rank

81.46%
PEN annual revenue is higher than 81.46% of companies in Healthcare sector

EPS

EPS

$0.36
PEN annual earnings per share is $0.36

EPS Analysts estimate

$3.41
PEN annual earnings per share is currently -89.44% lower than the consensus analysts' forecast

EPS 1-year change

-84.48%
PEN annual earnings per share is down -84.48% year-on-year

EPS Sector rank

86.06%
PEN annual earnings per share is higher than 86.06% of companies in Healthcare sector

Profit

Gross profit

$755.00M
PEN annual gross profit is $755.00 million

Gross margin

63.20%
PEN annual gross profit margin is 63.20%

Operating profit

$86.22M
PEN annual operating income is $86.22 million

Operating margin

7.22%
PEN annual operating profit margin is 7.22%

Net income

$14.01M
PEN annual net profit is $14.01 million

Net margin

1.17%
PEN annual net profit margin is 1.17%

Expenses

Total expenses

$1.11B
PEN annual total expenses is $1.11 billion

Operating expenses

$668.77M
PEN annual total operating expenses is $668.77 million

Cost of goods sold

$439.62M
PEN annual cost of goods sold is $439.62 million

Selling, general & administrative expenses

$573.99M
PEN annual SGA is $573.99 million

Depreciation and amortization

$23.70M
PEN annual depreciation & amortization is $23.70 million

Interest expense

$1.42M
PEN annual interest expense is $1.42 million

Income tax

$6.86M
PEN annual income tax is $6.86 million

EBIT & EBITDA

EBIT

$22.29M
PEN annual earnings before interest & taxes is $22.29 million

EBITDA

$45.99M
PEN annual EBITDA is $45.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.53B
PEN annual total assets is $1.53 billion

Non current assets

$582.06M
PEN annual long term assets is $582.06 million

Current assets

$951.13M
PEN annual total current assets is $951.13 million

Cash and cash equivalents

$324.40M
PEN annual cash & cash equivalents is $324.40 million

Accounts receivable

$167.67M
PEN annual accounts receivable is $167.67 million

Inventory

$406.74M
PEN annual inventory is $406.74 million

Liabilities

Total liabilities

$382.25M
PEN annual total liabilities is $382.25 million

Long term liabilities

$223.91M
PEN annual total long term liabilities is $223.91 million

Current liabilities

$158.34M
PEN annual total current liabilities is $158.34 million

Accounts payable

$31.33M
PEN annual accounts payable is $31.33 million

Debt

Total debt

$223.39M
PEN annual total debt is $223.39 million

Total debt 1-year change

-4.67%
PEN annual total debt is down -4.67% year-on-year

Long term debt

$208.80M
PEN annual long term debt is $208.80 million

Short term debt

$14.59M
PEN annual short term debt is $14.59 million

Equity & Capital

Shareholders equity

$1.15B
PEN annual stockholders equity is $1.15 billion

Book value

$1.15B
PEN annual book value is $1.15 billion

Retained earnings

$60.00M
PEN annual retained earnings is $60.00 million

Working capital

$792.78M
PEN annual working capital is $792.78 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$168.48M
PEN annual cash flow from operations is $168.48 million

Cash from operations 1-year change

+73.1%
PEN annual cash flow from operations is up +73.1% year-on-year

Cash from investing

$77.62M
PEN annual cash flow from investing activities is $77.62 million

Cash from investing 1-year change

+582.86%
PEN annual cash flow from investing activities is up +582.86% year-on-year

Cash from financing

-$87.01M
PEN annual cash flow from financing activities is -$87.01 million

Cash from financing 1-year change

-636.97%
PEN annual cash flow from financing activities is down -636.97% year-on-year

CAPEX

CAPEX

$21.18M
PEN annual capital expenditures is $21.18 million

CAPEX 1-year change

+39.24%
PEN annual capital expenditures is up +39.24% year-on-year

Free Cash Flow

Free cash flow

$147.30M
PEN annual free cash flow is $147.30 million

Free cash flow 1-year change

+79.37%
PEN annual free cash flow is up +79.37% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

63.20%
PEN annual gross profit margin is 63.20%

Operating margin

7.22%
PEN annual operating profit margin is 7.22%

Net margin

1.17%
PEN annual net profit margin is 1.17%

ROA & ROE

ROA

0.91%
PEN annual return on assets is 0.91%

ROE

1.20%
PEN annual return on equity is 1.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

281.37
PEN price to earnings ratio is 281.37

PE ratio Sector rank

96.08%
PEN price to earnings ratio is higher than 96.08% of companies in Healthcare sector

PB Ratio

PB ratio

11.09
PEN price to book ratio is 11.09

PB ratio Sector rank

92.86%
PEN price to book ratio is higher than 92.86% of companies in Healthcare sector

PS Ratio

PS ratio

9.30
PEN price to sales ratio is 9.30

PS ratio Sector rank

76.36%
PEN price to sales ratio is higher than 76.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.38B
PEN enterprise value is $11.38 billion

Enterprise value Sector rank

92.91%
PEN enterprise value is higher than 92.91% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

156.70
PEN EV/EBITDA is 156.70

EV/EBITDA Sector rank

99.21%
PEN EV/EBITDA is higher than 99.21% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.01
PEN annual current ratio is 6.01

Quick ratio

3.44
PEN annual quick ratio is 3.44

Leverage

Debt to equity

0.00
PEN annual debt to equity ratio is 0.00

Interest coverage ratio

15.72
PEN annual interest coverage ratio is 15.72

Risk & Stability

Piotroski F-Score

9
PEN piotroski f-score is 9

Altman Z-Score

19.61
PEN altman z-score is 19.61

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Buy
Mar 14, 25 B of A Securities
Buy
Feb 19, 25 Wells Fargo
Overweight
Feb 19, 25 UBS
Buy
Feb 19, 25 Truist Securities
Buy
Feb 19, 25 RBC Capital
Outperform
Feb 19, 25 Piper Sandler
Overweight
Feb 19, 25 Needham
Hold
Feb 19, 25 Morgan Stanley
Equal-Weight
Feb 19, 25 JP Morgan
Overweight

Institutional Ownership

Similar stocks

RVTY logo
Revvity (RVTY)
RDY logo
Dr Reddys Laboratories Limited (RDY)
INCY logo
Incyte (INCY)
SOLV logo
Solventum (SOLV)
UHS logo
Universal Health Services (UHS)
ICLR logo
ICON Public Limited (ICLR)
SNN logo
Smith & Nephew (SNN)
THC logo
Tenet Healthcare (THC)
DVA logo
DaVita (DVA)
  • What is the ticker symbol for Penumbra?
  • Does Penumbra pay dividends?
  • What sector is Penumbra in?
  • What industry is Penumbra in?
  • What country is Penumbra based in?
  • When did Penumbra go public?
  • Is Penumbra in the S&P 500?
  • Is Penumbra in the NASDAQ 100?
  • Is Penumbra in the Dow Jones?
  • When was Penumbra's last earnings report?
  • When does Penumbra report earnings?
  • Should I buy Penumbra stock now?

What is the ticker symbol for Penumbra?

The ticker symbol for Penumbra is NYSE:PEN

Does Penumbra pay dividends?

No, Penumbra does not pay dividends

What sector is Penumbra in?

Penumbra is in the Healthcare sector

What industry is Penumbra in?

Penumbra is in the Medical Devices industry

What country is Penumbra based in?

Penumbra is headquartered in United States

When did Penumbra go public?

Penumbra's initial public offering (IPO) was on September 18, 2015

Is Penumbra in the S&P 500?

No, Penumbra is not included in the S&P 500 index

Is Penumbra in the NASDAQ 100?

No, Penumbra is not included in the NASDAQ 100 index

Is Penumbra in the Dow Jones?

No, Penumbra is not included in the Dow Jones index

When was Penumbra's last earnings report?

Penumbra's most recent earnings report was on Apr 23, 2025

When does Penumbra report earnings?

The next expected earnings date for Penumbra is Jul 30, 2025

Should I buy Penumbra stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page